23andMe Licensed an Antibody for IBD Based on Its Ancestry Database
March 17, 2020 | Terry Sharrer
Developing drugs from antibodies
“23andMe Inc., the Silicon Valley firm known for its ancestry DNA tests, has licensed an antibody it developed to treat inflammatory diseases to Spanish drug maker Almirall SA.” The antibody derived from the database of 23andMe’s 10 million users. MORE
Image Credit: pixnio
